Subscribe to RSS

DOI: 10.1055/s-0043-1778687
Petrous Chondrosarcoma: Case Study of Two Patients with Surgical Nuances and Literature Review
Authors
Abstract
Primary chondrosarcoma of the skull base is a malignant tumor made up of cells developed from aberrant chondrocytes that occurs in 0.1 to 0.2% of all skull base lesions. Skull base lesions are challenging not just because of their location, but also because critical local neurovascular structures are involved. Thus, we will examine two cases with varying presentations and study the literature to evaluate various surgical management options and their nuances.
Authors' Contribution
All the authors prepared and reviewed the manuscript. A.S. and M.J. reviewed the literature. V.S. examined the surgical specimen for pathology.
Publication History
Article published online:
29 May 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Bloch O, Parsa AT. Skull base chondrosarcoma: evidence-based treatment paradigms. Neurosurg Clin N Am 2013; 24 (01) 89-96
- 2 Awad M, Gogos AJ, Kaye AH. Skull base chondrosarcoma. J Clin Neurosci 2016; 24: 1-5
- 3 Rosenberg AE, Nielsen GP, Keel SB. et al. Chondrosarcoma of the base of the skull: a clinicopathologic study of 200 cases with emphasis on its distinction from chordoma. Am J Surg Pathol 1999; 23 (11) 1370-1378
- 4 Arpino L, Capuano C, Gravina M, Franco A. Parasellar myxoid chondrosarcoma: a rare variant of cranial chondrosarcoma. J Neurosurg Sci 2011; 55 (04) 387-389
- 5 Singh AK, Srivastava AK, Sardhara J. et al. Skull base bony lesions: Management nuances; a retrospective analysis from a tertiary care centre. Asian J Neurosurg 2017; 12 (03) 506-513
- 6 Louis DN, Perry A, Wesseling P. et al. The 2021 WHO Classification of tumors of the central nervous system: a summary. Neuro-oncol 2021; 23 (08) 1231-1251
- 7 Ceylan S, Koc K, Anik I. Extended endoscopic approaches for midline skull-base lesions. Neurosurg Rev 2009; 32 (03) 309-319 , discussion 318–319
- 8 Prevedello DM, Doglietto F, Jane Jr JA, Jagannathan J, Han J, Laws Jr ER. History of endoscopic skull base surgery: its evolution and current reality. J Neurosurg 2007; 107 (01) 206-213
- 9 Grunert P, Darabi K, Espinosa J, Filippi R. Computer-aided navigation in neurosurgery. Neurosurg Rev 2003; 26 (02) 73-99 , discussion 100–101
- 10 Wiltfang J, Rupprecht S, Ganslandt O. et al. Intraoperative image-guided surgery of the lateral and anterior skull base in patients with tumors or trauma. Skull Base 2003; 13 (01) 21-29
- 11 Weber DC, Badiyan S, Malyapa R. et al. Long-term outcomes and prognostic factors of skull-base chondrosarcoma patients treated with pencil-beam scanning proton therapy at the Paul Scherrer Institute. Neuro-oncol 2016; 18 (02) 236-243
- 12 Lu VM, O'Connor KP, Mahajan A, Carlson ML, Van Gompel JJ. Carbon ion radiotherapy for skull base chordomas and chondrosarcomas: a systematic review and meta-analysis of local control, survival, and toxicity outcomes. J Neurooncol 2020; 147 (03) 503-513

